HIP-ARTHROPLASTY IN PATIENTS WITH SICKLE-CELL HEMOGLOBINOPATHY

被引：82

作者：

ACURIO, MT ^{[1
]}

FRIEDMAN, RJ ^{[1
]}

机构：

[1] MED UNIV S CAROLINA, DEPT ORTHOPAED SURG, 171 ASHLEY AVE, CHARLESTON, SC 29425 USA

来源：

JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME | 1992年 / 74卷 / 03期

关键词：

D O I：

10.1302/0301-620X.74B3.1587879

中图分类号：

R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];

学科分类号：

摘要：

We reviewed retrospectively 25 hip arthroplasties in 25 patients with sickle-cell haemoglobinopathy and osteonecrosis. The mean age of the ten women and 15 men at the onset of hip symptoms was 25 years, and at surgery 30 years (16 to 45); 66% had either SS or S-thal disease, 20% sickle-cell trait, and the remainder SC disease. The mean follow-up was 8.6 years (two to 18). Fourteen (40%) of the arthroplasties had been revised at a mean of 7.5 years after the primary procedure and nine other hips were either radiographically and/or symptomatically loose. The overall complication rate was 49% and the infection rate 20%. The risk-to-benefit ratio of hip arthroplasty in sickle-cell haemoglobinopathy is high.

引用

页码：367 / 371

页数：5